Hollysys Automation Technologies Wins Bidding from Tianjin Metro to Supply SCADA System

Hollysys Automation Technologies, Ltd. ("Hollysys" or the "Company"), a leading provider of automation and control technologies and applications in China, announced today that it won the bidding from Tianjin Metro to supply the supervisory control and data acquisition system (SCADA) to Tianjin Subway Line 5, valued at approximately USD $13.88 million or RMB 85.02 million.

Tianjin Subway Line 5 is a mass transit subway line connecting Science Park in Beichen District in the north and Liqizhuang in Xiqing District in the south of Tianjin, with 30 stations and 33.6 km in total length. The construction is including three phases. The Phase 1 is scheduled to be completed by the end of 2015, the phase 2 is scheduled to be completed by September 2016, and the whole line is scheduled to be in trail operation by October 2017.

Hollysys is contracted to provide SCADA system based on its proprietary MACS-SCADA software platform, including software platform, system design, application development, hardware integration, installation, testing, maintenance and services. Hollysys will also provide its proprietary LM PLC to its PSCADA (Power SCADA) and apply total solution based on our previous successful experience in Beijing, Guangzhou, Shenzhen subway lines to ensure local customers' needs and design requirements as well as technology application are satisfied overall.

Hollysys' management commented, "We are very pleased to win the bidding from Tianjin Metro to supply our proprietary SCADA systems for Tianjin Subway Line 5. As China's subway ramp-up accelerates nationwide, Hollysys will continue to leverage on its solid and successful track record to gain its fair share in this booming market, further validates our well-established brand name recognition in China's fast-growing subway automation market, and create value for our shareholders."

About Hollysys Automation Technologies, Ltd. (NASDAQ: HOLI)

Hollysys Automation Technologies is a leading provider of automation and control technologies and applications in China that enables its diversified industry and utility customers to improve operating safety, reliability, and efficiency. Founded in 1993, Hollysys has approximately 3,600 employees with nationwide presence in over 60 cities in China, with subsidiaries and offices in Singapore, Malaysia, Dubai, India, and serves over 5,000 customers more than 20,000 projects in the industrial, railway, subway & nuclear industries in China, South-East Asia, and the Middle East. Its proprietary technologies are applied in its industrial automation solution suite including DCS (Distributed Control System), PLC (Programmable Logic Controller), RMIS (Real-time Management Information System), HAMS (HolliAS Asset Management System), OTS (Operator Training System), HolliAS BATCH (Batch Application Package), HolliAS APC Suite (Advanced Process Control Package), SIS (Safety Instrumentation System), high-speed railway signaling system of TCC (Train Control Center), ATP (Automatic Train Protection), Subway Supervisory and Control platform, SCADA (Surveillance Control and Data Acquisition), nuclear power plant automation and control system and other products.

Source: http://www.hollysys.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.